SG11201503432SA - Monoclonal antibody against muramyl peptides - Google Patents
Monoclonal antibody against muramyl peptidesInfo
- Publication number
- SG11201503432SA SG11201503432SA SG11201503432SA SG11201503432SA SG11201503432SA SG 11201503432S A SG11201503432S A SG 11201503432SA SG 11201503432S A SG11201503432S A SG 11201503432SA SG 11201503432S A SG11201503432S A SG 11201503432SA SG 11201503432S A SG11201503432S A SG 11201503432SA
- Authority
- SG
- Singapore
- Prior art keywords
- monoclonal antibody
- antibody against
- muramyl peptides
- against muramyl
- peptides
- Prior art date
Links
- 125000001446 muramyl group Chemical group N[C@@H](C=O)[C@@H](O[C@@H](C(=O)*)C)[C@H](O)[C@H](O)CO 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4722—Proteoglycans, e.g. aggreccan
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG11201503432SA SG11201503432SA (en) | 2012-11-01 | 2013-11-01 | Monoclonal antibody against muramyl peptides |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG2012080826 | 2012-11-01 | ||
| PCT/SG2013/000473 WO2014070117A1 (en) | 2012-11-01 | 2013-11-01 | Monoclonal antibody against muramyl peptides |
| SG11201503432SA SG11201503432SA (en) | 2012-11-01 | 2013-11-01 | Monoclonal antibody against muramyl peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201503432SA true SG11201503432SA (en) | 2015-05-28 |
Family
ID=54700992
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201503432SA SG11201503432SA (en) | 2012-11-01 | 2013-11-01 | Monoclonal antibody against muramyl peptides |
| SG10201705841YA SG10201705841YA (en) | 2012-11-01 | 2013-11-01 | Monoclonal antibody against muramyl peptides |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201705841YA SG10201705841YA (en) | 2012-11-01 | 2013-11-01 | Monoclonal antibody against muramyl peptides |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9695231B2 (en) |
| EP (1) | EP2909234A4 (en) |
| CN (1) | CN104797597B (en) |
| SG (2) | SG11201503432SA (en) |
| WO (1) | WO2014070117A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201503432SA (en) | 2012-11-01 | 2015-05-28 | Agency Science Tech & Res | Monoclonal antibody against muramyl peptides |
| WO2016114720A1 (en) * | 2015-01-12 | 2016-07-21 | Agency For Science, Technology And Research | Monoclonal antibody against muramyl peptides in prevention and treatment of immune-mediated diseases |
| US11174288B2 (en) | 2016-12-06 | 2021-11-16 | Northeastern University | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria |
| WO2020118042A1 (en) * | 2018-12-05 | 2020-06-11 | Jacobs Wagner Christine | Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2530957A1 (en) * | 1982-07-30 | 1984-02-03 | Anvar | PROCESS FOR SEPARATING OR PURIFYING A SLEEP-PROMOTING FACTOR FROM A BIOLOGICAL MEDIUM BY AN IMMUNOLOGICAL ANTIGEN-ANTIBODY REACTION |
| EP2061490B1 (en) | 2006-08-25 | 2017-11-08 | Agency for Science, Technology and Research | Modulators of candida hyphal morphogenesis and uses thereof |
| SG11201503432SA (en) | 2012-11-01 | 2015-05-28 | Agency Science Tech & Res | Monoclonal antibody against muramyl peptides |
| WO2016114720A1 (en) * | 2015-01-12 | 2016-07-21 | Agency For Science, Technology And Research | Monoclonal antibody against muramyl peptides in prevention and treatment of immune-mediated diseases |
-
2013
- 2013-11-01 SG SG11201503432SA patent/SG11201503432SA/en unknown
- 2013-11-01 SG SG10201705841YA patent/SG10201705841YA/en unknown
- 2013-11-01 EP EP13850865.0A patent/EP2909234A4/en not_active Ceased
- 2013-11-01 CN CN201380056321.7A patent/CN104797597B/en active Active
- 2013-11-01 US US14/436,002 patent/US9695231B2/en active Active
- 2013-11-01 WO PCT/SG2013/000473 patent/WO2014070117A1/en active Application Filing
-
2017
- 2017-05-19 US US15/600,203 patent/US10316079B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2909234A4 (en) | 2016-10-26 |
| CN104797597B (en) | 2019-02-01 |
| WO2014070117A1 (en) | 2014-05-08 |
| US9695231B2 (en) | 2017-07-04 |
| CN104797597A (en) | 2015-07-22 |
| US10316079B2 (en) | 2019-06-11 |
| EP2909234A1 (en) | 2015-08-26 |
| US20170260259A1 (en) | 2017-09-14 |
| SG10201705841YA (en) | 2017-08-30 |
| US20150344547A1 (en) | 2015-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180640T1 (en) | Anti-b7-h3 antibody | |
| IL259826A (en) | Anti-alphabetatcr antibody | |
| HK1209137A1 (en) | Humanized tau antibody tau | |
| ZA201400768B (en) | Interleukin-31 monoclonal antibody | |
| AP2014008102A0 (en) | Anti-FcRn antibodies | |
| EP2841082A4 (en) | Protease-regulated antibodies | |
| EP2722343A4 (en) | ANTI-erbB3 ANTIBODY | |
| EP2930240A4 (en) | Anti-folr1 antibody | |
| ZA201407316B (en) | Anti-fgfr2 antibody | |
| EP2830660A4 (en) | Anti-sema4d antibodies and epitopes | |
| EP2826790A4 (en) | Gremlin-1 antibody | |
| ZA201407079B (en) | Cdr-modified anti-siglec-15 antibody | |
| TWI563004B (en) | Anti-hxcr1 antibody | |
| EP2707392A4 (en) | Monoclonal antibody for acetylamantadine | |
| SG11201503432SA (en) | Monoclonal antibody against muramyl peptides | |
| GB201220242D0 (en) | Antibody | |
| EP2848633A4 (en) | Anti-cxadr antibody | |
| EP2771689A4 (en) | Usp2a peptides and antibodies | |
| EP2811018A4 (en) | ANTI-sAPPß ANTIBODY | |
| EP2769988A4 (en) | Anti-gap43 antibody |